Clinical applications of FDG-PET in oncology

被引：28

作者：

Czernin, J ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Clin, Los Angeles, CA 90024 USA

来源：

ACTA MEDICA AUSTRIACA | 2002年 / 29卷 / 05期

关键词：

positron emission tomography; oncology; FDG;

D O I：

10.1046/j.1563-2571.2002.02042.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Positron emission tomography together with F-18-deoxyglucose (FDG) has emerged as a valuable clinical tool in the field of oncology. FDG-PET diagnoses, stages and restages most cancers with a high diagnostic accuracy. The effects of chemotherapy on tumour metabolism can be monitored with this whole-body technique. Recent studies have established a high prognostic accuracy of PET for predicting the clinical outcome of cancer patients. The current review addresses the role of FDG-PET for diagnosing, staging and restaging of lung cancer, colorectal cancer, lymphoma, melanoma and breast cancer staging and provides a brief outlook for future applications of clinical PET imaging.

引用

收藏

页码：162 / 170

页数：9

相关论文

共 94 条

[31]

Gambhir SS, 2001, J NUCL MED, V42, p1S

[32] Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management [J].

Greco, M ;

Crippa, F ;

Agresti, R ;

Seregni, E ;

Gerali, A ;

Giovanazzi, R ;

Micheli, A ;

Asero, S ;

Ferraris, C ;

Gennaro, M ;

Bombardieri, E ;

Cascinelli, N .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) :630-635

[33] Lymph node staging in non-small cell lung cancer: Evaluation by [F-18]FDG positron emission tomography (PET) [J].

Guhlmann, A ;

Storck, M ;

Kotzerke, J ;

Moog, F ;

SunderPlassmann, L ;

Reske, SN .

THORAX, 1997, 52 (05) :438-441

[34]

Gupta NC, 1996, J NUCL MED, V37, P943

[35]

Hoh CK, 1997, J NUCL MED, V38, P343

[36] The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma [J].

Jadvar, H ;

Johnson, DL ;

Segall, GM .

CLINICAL NUCLEAR MEDICINE, 2000, 25 (01) :48-51

[37] Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging [J].

Jerusalem, G ;

Beguin, Y ;

Fassotte, MF ;

Najjar, F ;

Paulus, P ;

Rigo, P ;

Fillet, G .

BLOOD, 1999, 94 (02) :429-433

[38] MAJOR PULMONARY RESECTION FOR SUSPECTED BUT UNCONFIRMED MALIGNANCY [J].

KEAGY, BA ;

STAREK, PJK ;

MURRAY, GF ;

BATTAGLINI, JW ;

LORES, ME ;

WILCOX, BR .

ANNALS OF THORACIC SURGERY, 1984, 38 (04) :314-316

[39] THE SOLITARY PULMONARY NODULE - ASSESSMENT, DIAGNOSIS, AND MANAGEMENT [J].

KHOURI, NF ;

MEZIANE, MA ;

ZERHOUNI, EA ;

FISHMAN, EK ;

SIEGELMAN, SS .

CHEST, 1987, 91 (01) :128-133

[40] Evaluation of pulmonary lesions with FDG-PET - Comparison of findings in patients with and without a history of prior malignancy [J].

Knight, SB ;

Delbeke, D ;

Stewart, JR ;

Sandler, MP ;

Ebers, T .

CHEST, 1996, 109 (04) :982-988

← 1 2 3 4 5 6 7 8 9 10 →